Eric F Johnson

Title: The Innovations of Eric F Johnson

Introduction

Eric F Johnson is an accomplished inventor based in Antioch, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of 2 patents to his name, Johnson's work is recognized for its potential impact on medical treatments.

Latest Patents

Johnson's latest patents focus on "5-substituted indazoles as kinase inhibitors." The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein A, R, R, and m are defined in the description. This invention also encompasses methods of making said compounds and compositions containing these compounds, which are useful for inhibiting various kinases such as Glycogen Synthase kinase 3 (GSK-3), Rho kinase (ROCK), Janus Kinases (JAK), Cdc7, AKT, PAK4, PLK, CK2, KDR, MK2, JNK1, aurora, pim 1, and nek 2.

Career Highlights

Eric F Johnson is currently employed at AbbVie Inc., where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of diseases through targeted kinase inhibition.

Collaborations

Johnson collaborates with notable colleagues, including Irini Akritopoulou-Zanze and Brian D Wakefield. These partnerships enhance the research and development efforts within his field.

Conclusion

Eric F Johnson's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work in developing kinase inhibitors showcases the potential for innovative treatments in medicine.